Latest News - Skin Cancer

Tuesday, July 17, 2018

Save the Date: Skin Cancer Foundation's Champions for Change Gala this October

The Skin Cancer Foundation’s signature fundraising event, the Champions for Change Gala, is coming October 25 in New York City. Robert J. Friedman, MD will be honored as the 2019 Champ…

Read the full story

Thursday, July 12, 2018

Sensus Healthcare Forms Strategic Agreement with SkinCure Oncology

Sensus Healthcare, Inc., which specializes in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), formed a strategic agr…

Read the full story

Wednesday, July 11, 2018

Dermtech’s Noninvasive Melanoma Screen Improves Care, Lowers Cost

New research shows that DermTech’s Pigmented Lesion Assay (PLA) reduces cost while improving the care of patients with primary pigmented skin lesions suggestive of melanoma. The research appears…

Read the full story

Wednesday, July 11, 2018

Life Sciences Industry Eyes $1.5 Trillion Milestone

The life sciences industry is nearing a $1.5 trillion milestone, according to an analysis from Frost & Sullivan. The firm’s Global Life Sciences Industry Outlook, 2018 report finds that…

Read the full story

Monday, July 02, 2018

BrightGuard Installs Free Sunscreen Dispensers at New York City Public Pools and Beaches

Through its ongoing partnership with non-profit sponsor and donor IMPACT Melanoma and sunscreen provider Coppertone, BrightGuard has installed 134 sunscreen dispensers throughout New York City (NYC) p…

Read the full story

Wednesday, June 27, 2018

FDA Approves Braftovi in Combination with Mektovi for Advanced BRAF-mutant Melanoma

The FDA has approved Array BioPharma Inc.'s BRAFTOVI (encorafenib) capsules in combination with MEKTOVI (binimetinib) tablets for the treatment of patients with unresectable or metastatic melanoma…

Read the full story

Tuesday, June 26, 2018

DermTech Initiating Study to Assess DNA Damage and Reversal

DermTech, Inc. has initiated enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of T4 endonuclease topical DNA repair enzyme and photolyase…

Read the full story

Friday, June 15, 2018

New Data from DermTech Presented at International Investigational Dermatology Meeting

DermTech, Inc., has announced the publication of two clinical study abstracts at the 2018 International Investigational Dermatology meeting in Orlando, Fl. A real world clinical utility study, “…

Read the full story

Wednesday, June 13, 2018

Older Melanoma Patients May Have Better Response to Immune Checkpoint Blockade Therapy

Patient age correlates with response to immunotherapy in melanoma, and depleting regulatory T cells in young patients may have a therapeutic potential to enhance response in younger patients, accordin…

Read the full story

Friday, June 08, 2018

PellePharm Presents New Data in BCC

PellePharm, a late clinical-stage biopharmaceutical company committed to targeting rare dermatologic conditions at their source, presented new data from its clinical and scientific research programs a…

Read the full story

Friday, June 08, 2018

Opdivo Data: Superior Recurrence-Free Survival Versus Ipilimumab

Updated results from the Phase 3 CheckMate -238 trial evaluating Opdivo (nivolumab, Bristol-Myers Squibb Company) versus Yervoy (ipilimumab, Bristol-Myers Squibb Company) …

Read the full story

Monday, June 04, 2018

PD1 Blocker Shrinks Advanced Squamous Cell Skin Cancers

A checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of squamous cell carcinoma, an international team reports in the New England Journal of Medic…

Read the full story

Thursday, May 31, 2018

Skin Cancer Survey Spotlights Frustration with Perceptions of "Less Serious" Condition

People living with skin cancer struggle with perceptions that their condition is less serious than other types of cancer despite significant physical and emotional impact, according to Skin Cancer In …

Read the full story

Tuesday, May 29, 2018

DermTech: Carcinome Clinical Study Enrollment Complete

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced completion of enrollment in the Carcinome™ clinical study. The goal of the Carcinome™ study is to develop…

Read the full story

Tuesday, May 29, 2018

New Dermatologic Surgery Textbook by McGraw-Hill Enters Second Printing Less Than One Week After Publication

McGraw-Hill has just released Jonathan Kantor’s new 1,440-page textbook, Dermatologic Surgery, the most comprehensive and richly illustrated dermatologic surgery textbook ever published, an…

Read the full story
Load More